Eye Drops Ready for Licensing-out
Developed and produced in EU
Proven and fast relief for eye problems
Preservative free
1 click - 1 drop
Proven safety
Vizol S Product Family
A range of eye drops to help relieve dry eye symptoms
Innovative & preservative free formulation
Complementary ingredients which work in perfect synergy to deliver superior performance.
Hyaluronic Acid
moisturising and quick relief for dry eye symptoms
Dexpanthenol
regeneration of micro damages of eye surface
Shelf life
36 months
Period after opening
6 months
Unique & patented
formulations
Pharmaceutical form
Eye drops, solution
Vizol S Product Line
Vizol S 0,1%
Indication
Relief of milder dry eye symptoms
Composition
Sodium hyaluronate 0,1%
Number of doses
350
Dossier available
According to EU medical device regulation
Regulatory classification
Medical device
Vizol S Fast Relief
Indication
Relief of mild dry eye problems
Composition
Sodium hyaluronate 0,21%
Number of doses
350
Dossier available
According to EU medical device regulation
Regulatory classification
Medical device
Vizol S Long Effect
Indication
Relief of severe dry eye problems
Composition
Sodium hyaluronate 0,4%
Number of doses
350
Dossier available
According to EU medical device regulation
Regulatory classification
Medical device
Vizol S Intensive
Indication
Relief of dry eye problems and regeneration of eye surface
Composition
Sodium hyaluronate 0,15% + dexpanthenol 2%
Number of doses
450
Dossier available
According to EU medical device regulation
Regulatory classification
Medical device
Viset Eye Drops
Eye drops to help relieve eye redness and allergic eye inflammation.
First preservative free formulation registered in EU.
Effects of Tetryzoline hydrocloride deliver superior performance.
Vasoconstriction
sympathomimetic, narrowing the blood vessels of the conjunctival mucosa
Decongesting
the mucous membrane
Shelf life
36 months
Shelf life
30 months
Period after opening
28 days
Pharmaceutical form
Eye drops, solution
Viset
Indication
Relief of eye redness and allergic eye inflammation
Composition
Tetryzoline hydrocloride 0.5 mg/ml
Dossier available
eCTD, the 1st PF formulation registered in EU
Regulatory classification
OTC drug
New innovative products in research and development pipeline.
Our Partners
We nurture collaboration with renowned pharmaceutical companies based on a strategic approach, flexibility, top professionalism and extensive experience.
